120 related articles for article (PubMed ID: 34320905)
1. One microsecond MD simulations of the SARS-CoV-2 main protease and hydroxychloroquine complex reveal the intricate nature of binding.
Kumar P; Bhardwaj T; Kumar A; Garg N; Giri R
J Biomol Struct Dyn; 2022; 40(21):10763-10770. PubMed ID: 34320905
[TBL] [Abstract][Full Text] [Related]
2. Identification of potent COVID-19 main protease inhibitors by loading of favipiravir on Mg
Al-Shuaeeb RAA; Abd El-Mageed HR; Ahmed SA; Mohamed HS; Hamza ZS; Rafi MO; Rahman MS
J Biomol Struct Dyn; 2023; 41(21):11437-11449. PubMed ID: 36591698
[TBL] [Abstract][Full Text] [Related]
3. Understanding the binding mechanism for potential inhibition of SARS-CoV-2 Mpro and exploring the modes of ACE2 inhibition by hydroxychloroquine.
Choudhury M; Dhanabalan AK; Goswami N
J Cell Biochem; 2022 Feb; 123(2):347-358. PubMed ID: 34741481
[TBL] [Abstract][Full Text] [Related]
4. Depicting the inhibitory potential of polyphenols from
Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
J Biomol Struct Dyn; 2022 Jun; 40(9):4110-4121. PubMed ID: 33292085
[TBL] [Abstract][Full Text] [Related]
5. Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study.
Reyaz S; Tasneem A; Rai GP; Bairagya HR
J Mol Graph Model; 2021 Dec; 109():108021. PubMed ID: 34537554
[TBL] [Abstract][Full Text] [Related]
6. Some Flavolignans as Potent Sars-Cov-2 Inhibitors
Cetin A
Curr Comput Aided Drug Des; 2022; 18(5):337-346. PubMed ID: 35975852
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an
Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
J Biomol Struct Dyn; 2021 Aug; 39(12):4362-4374. PubMed ID: 32568613
[TBL] [Abstract][Full Text] [Related]
8. Hunting the main protease of SARS-CoV-2 by plitidepsin: Molecular docking and temperature-dependent molecular dynamics simulations.
Vishvakarma VK; Singh MB; Jain P; Kumari K; Singh P
Amino Acids; 2022 Feb; 54(2):205-213. PubMed ID: 34807314
[TBL] [Abstract][Full Text] [Related]
9. Targeting allosteric pockets of SARS-CoV-2 main protease M
Bhat ZA; Chitara D; Iqbal J; Sanjeev BS; Madhumalar A
J Biomol Struct Dyn; 2022 Sep; 40(14):6603-6618. PubMed ID: 33645457
[TBL] [Abstract][Full Text] [Related]
10. Computational investigation of binding of chloroquinone and hydroxychloroquinone against PLPro of SARS-CoV-2.
Patel D; Athar M; Jha PC
J Biomol Struct Dyn; 2022 Apr; 40(7):3071-3081. PubMed ID: 33200683
[TBL] [Abstract][Full Text] [Related]
11. Computational study for identifying promising therapeutic agents of hydroxychloroquine analogues against SARS-CoV-2.
Prasanth DSNBK; Murahari M; Chandramohan V; Guntupalli C; Atmakuri LR
J Biomol Struct Dyn; 2022; 40(22):11822-11836. PubMed ID: 34396938
[TBL] [Abstract][Full Text] [Related]
12. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors.
Uniyal A; Mahapatra MK; Tiwari V; Sandhir R; Kumar R
J Biomol Struct Dyn; 2022 May; 40(8):3609-3625. PubMed ID: 33226303
[TBL] [Abstract][Full Text] [Related]
13. Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery.
Ray AK; Sen Gupta PS; Panda SK; Biswal S; Bhattacharya U; Rana MK
Comput Biol Med; 2022 Mar; 142():105183. PubMed ID: 34986429
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation.
Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ
Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591
[TBL] [Abstract][Full Text] [Related]
15. Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis.
Razzaghi-Asl N; Ebadi A; Shahabipour S; Gholamin D
J Biomol Struct Dyn; 2021 Oct; 39(17):6633-6648. PubMed ID: 32705953
[TBL] [Abstract][Full Text] [Related]
16. Antitussive noscapine and antiviral drug conjugates as arsenal against COVID-19: a comprehensive chemoinformatics analysis.
Kumar N; Awasthi A; Kumari A; Sood D; Jain P; Singh T; Sharma N; Grover A; Chandra R
J Biomol Struct Dyn; 2022 Jan; 40(1):101-116. PubMed ID: 32815796
[TBL] [Abstract][Full Text] [Related]
17. Computational study on the affinity of potential drugs to SARS-CoV-2 main protease.
Martín V; Sanz-Novo M; León I; Redondo P; Largo A; Barrientos C
J Phys Condens Matter; 2022 May; 34(29):. PubMed ID: 35504274
[TBL] [Abstract][Full Text] [Related]
18. Computer aided identification of potential SARS CoV-2 main protease inhibitors from diterpenoids and biflavonoids of
Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
J Biomol Struct Dyn; 2022 Apr; 40(6):2647-2662. PubMed ID: 33140695
[TBL] [Abstract][Full Text] [Related]
19. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.
Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R
J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685
[TBL] [Abstract][Full Text] [Related]
20. Sterenin M as a potential inhibitor of SARS-CoV-2 main protease identified from MeFSAT database using molecular docking, molecular dynamics simulation and binding free energy calculation.
Prajapati J; Patel R; Goswami D; Saraf M; Rawal RM
Comput Biol Med; 2021 Aug; 135():104568. PubMed ID: 34174757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]